Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Mutgan, AC; Jandl, K; Radic, N; Valzano, F; Kolb, D; Hoffmann, J; Foris, V; Wilhelm, J; Boehm, PM; Hoetzenecker, K; Olschewski, A; Olschewski, H; Heinemann, A; Wygrecka, M; Marsh, LM; Kwapiszewska, G.
Pentastatin, a matrikine of the collagen IVα5, is a novel endogenous mediator of pulmonary endothelial dysfunction.
Am J Physiol Cell Physiol. 2023; 325(5):C1294-C1312
Doi: 10.1152/ajpcell.00391.2023
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Kwapiszewska-Marsh Grazyna
- Mutgan Redolfi Ayse Ceren
- Co-Autor*innen der Med Uni Graz
- Foris Vasile
- Heinemann Akos
- Hoffmann Julia
- Jandl Katharina
- Kolb Dagmar
- Marsh Leigh
- Olschewski Andrea
- Olschewski Horst
- Radic Nemanja
- Valzano Francesco
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Deposition of basement membrane components, such as collagen IVα5, is associated with altered endothelial cell function in pulmonary hypertension. Collagen IVα5 harbors a functionally active fragment within its C-terminal noncollageneous (NC1) domain, called pentastatin, whose role in pulmonary endothelial cell behavior remains unknown. Here, we demonstrate that pentastatin serves as a mediator of pulmonary endothelial cell dysfunction, contributing to pulmonary hypertension. In vitro, treatment with pentastatin induced transcription of immediate early genes and proinflammatory cytokines and led to a functional loss of endothelial barrier integrity in pulmonary arterial endothelial cells. Mechanistically, pentastatin leads to β1-integrin subunit clustering and Rho/ROCK activation. Blockage of the β1-integrin subunit or the Rho/ROCK pathway partially attenuated the pentastatin-induced endothelial barrier disruption. Although pentastatin reduced the viability of endothelial cells, smooth muscle cell proliferation was induced. These effects on the pulmonary vascular cells were recapitulated ex vivo in the isolated-perfused lung model, where treatment with pentastatin-induced swelling of the endothelium accompanied by occasional endothelial cell apoptosis. This was reflected by increased vascular permeability and elevated pulmonary arterial pressure induced by pentastatin. This study identifies pentastatin as a mediator of endothelial cell dysfunction, which thus might contribute to the pathogenesis of pulmonary vascular disorders such as pulmonary hypertension.NEW & NOTEWORTHY This study is the first to show that pentastatin, the matrikine of the basement membrane (BM) collagen IVα5 polypeptide, triggers rapid pulmonary arterial endothelial cell barrier disruption, activation, and apoptosis in vitro and ex vivo. Mechanistically, pentastatin partially acts through binding to the β1-integrin subunit and the Rho/ROCK pathway. These findings are the first to link pentastatin to pulmonary endothelial dysfunction and, thus, suggest a major role for BM-matrikines in pulmonary vascular diseases such as pulmonary hypertension.
- Find related publications in this database (using NLM MeSH Indexing)
- Humans - administration & dosage
- Hypertension, Pulmonary - chemically induced, drug therapy, metabolism
- Endothelial Cells - metabolism
- Lung - metabolism
- Endothelium - metabolism
- Pulmonary Artery - metabolism
- Collagen - metabolism
- Integrins - metabolism
- Find related publications in this database (Keywords)
- collagen IV alpha 5
- endothelial dysfunction
- matrikine
- pentastatin
- pulmonary hypertension